新近发病糖尿病及新型糖尿病亚型患者的黄斑灌注改变
本研究为横断面研究,纳入德国糖尿病研究中的1型糖尿病143例、2型糖尿病197例及年龄性别匹配对照105例,采用光学相干断层扫描血管成像评估黄斑毛细血管。结果显示2型糖尿病在临床诊断时即出现浅层毛细血管丛灌注密度和血管密度降低,且病程10年时1型和2型糖尿病均出现浅层和深层毛细血管丛灌注密度降低。
要点
- 2型糖尿病在临床诊断时浅层毛细血管丛灌注密度和血管密度已降低
- 病程10年时1型和2型糖尿病均出现浅层和深层毛细血管丛灌注密度降低
- 黄斑微血管瘤与神经节细胞层和内丛状层厚度降低相关
核心结论
- 2型糖尿病在临床诊断时即降低黄斑浅层毛细血管丛灌注,而长期糖尿病影响浅层和深层毛细血管丛。
- 浅层毛细血管丛的黄斑无血管区和脉络膜毛细血管血流缺损密度是糖尿病改变的早期指标,在2型糖尿病中变化更明显。
- 黄斑毛细血管丛的微血管瘤与神经节细胞层和内丛状层厚度降低相关。
- 亚临床微血管病变出现在糖尿病视网膜病变、疾病相关视力损害或内层视网膜变薄之前。
研究设计与样本
- 横断面研究,纳入德国糖尿病研究(ClinicalTrials.gov注册号NCT01055093)中1型糖尿病143例和2型糖尿病197例,对照105例。
- 采用BMI、年龄、HbA1c、稳态模型评估和胰岛自身抗体进行聚类分析以识别基于表型的糖尿病亚型。
- 在糖尿病诊断后第一年(基线)及之后每5年直至第10年进行彩色眼底摄影、光学相干断层扫描和光学相干断层扫描血管成像。
主要发现
- 基线时2型糖尿病浅层毛细血管丛灌注密度较对照降低(预期差值-0.0071,p=0.0276),血管密度较对照降低(预期差值-0.0034,p=0.0184)。
- 第10年时1型和2型糖尿病仅浅层和深层毛细血管丛灌注密度降低(p=0.0365,p=0.0062)。
- 第一年内1型糖尿病黄斑无血管区扩大(p=0.0327)和脉络膜毛细血管血流缺损密度增加(p=0.0474),2型糖尿病更明显(p=0.0006,p<0.0001)。
- 浅层和深层毛细血管丛微血管瘤在第5年(p=0.0209,p=0.0279)和第10年(p=0.0220,p=0.0007)显著。
- 浅层和深层毛细血管丛微血管瘤与浅层和中间毛细血管丛灌注密度及血管密度降低相关,并与神经节细胞层和内丛状层厚度降低相关。
关键数值与推荐
- 基线时2型糖尿病浅层毛细血管丛灌注密度预期差值-0.0071(p=0.0276),血管密度预期差值-0.0034(p=0.0184),与对照比较。
- 第10年1型和2型糖尿病浅层毛细血管丛灌注密度p=0.0365,深层毛细血管丛灌注密度p=0.0062。
- 第一年内1型糖尿病黄斑无血管区p=0.0327,脉络膜毛细血管血流缺损密度p=0.0474;2型糖尿病黄斑无血管区p=0.0006,脉络膜毛细血管血流缺损密度p<0.0001。
- 浅层毛细血管丛微血管瘤第5年p=0.0209,第10年p=0.0220;深层毛细血管丛微血管瘤第5年p=0.0279,第10年p=0.0007。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Our aim was to detect early structural and functional changes in the macular capillaries using optical coherence tomography angiography during the course of type 1 or 2 diabetes mellitus. METHODS: In this cross-sectional study, individuals with type 1 diabetes (n=143) or type 2 diabetes (n=197) from the German Diabetes Study (ClinicalTrials.gov registration no. NCT01055093) underwent clinical examination and cluster analysis to identify phenotype-based diabetes subtypes, using BMI, age, HbA1c, homoeostasis model estimates and islet autoantibodies. Colour fundus photography, optical coherence tomography and optical coherence tomography angiography were performed within the first year of diabetes diagnosis (baseline) and at 5 year intervals up to year 10. Age- and sex-adjusted participants served as control participants (n=105). Perfusion density, vessel density, presence of retinal microaneurysms in superficial, intermediate and deep capillary plexus (SCP, ICP, DCP), choriocapillaris flow deficit density (CC FD) and the foveal avascular zone (FAZ) of the macula as well as retinal layer thickness, visual acuity and contrast sensitivity were analysed. RESULTS: Perfusion density and vessel density of SCP were already reduced at baseline in type 2 diabetes (expected difference compared with control participants: -0.0071, p=0.0276, expected difference: -0.0034, p=0.0184, respectively), especially in participants with severe insulin-deficient and mild obesity-related diabetes. At year 10 only perfusion density of the SCP and DCP was reduced in both type 1 and 2 diabetes (p=0.0365, p=0.0062, respectively). The FAZ was enlarged and the CC FD within the first year increased in type 1 (p=0.0327, p=0.0474, respectively) and more markedly in type 2 diabetes (p=0.0006, p<0.0001). The occurrence of microaneurysms in SCP and DCP was significant at year 5 (p=0.0209, p=0.0279, respectively) and year 10 (p=0.0220, p=0.0007). Presence of microaneurysms in SCP and DCP was associated with decreases in perfusion density and vessel density in both SCP and ICP. Furthermore, microaneurysms were associated with decreased ganglion cell layer and inner plexiform layer thickness. CONCLUSIONS/INTERPRETATION: Type 2 diabetes already reduces macular perfusion SCP at time of clinical diagnosis, while long-standing diabetes affects both SCP and DCP. The FAZ of the SCP and the CC FD are early indicators of diabetic alterations, with more pronounced changes observed in type 2 diabetes. Microaneurysms in the macular plexus are associated with a decrease of ganglion cell layer and inner plexiform layer. Subclinical microangiopathy occurs prior to manifestation of diabetic retinopathy, disease-related visual acuity impairment or inner retinal layer thinning.
引用
- Kaya S, Khamees A, Geerling G, et al. Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes. Diabetologia. 2025. PMID: 40164944. doi:10.1007/s00125-025-06407-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。